heme101
跨領域 › 血液急症

上腔靜脈症候群

Superior Vena Cava (SVC) Syndrome
跨領域 未策展 更新 2026-08-02

概覽

Buzzwords → Dx

Buzzword Diagnosis / Clue
Facial / neck / arm swelling + dilated chest collaterals + dyspnea SVC syndrome
Pemberton sign (facial plethora when arms raised) Classic SVC sign
Stridor / orthopnea Airway compromise — emergent
Cerebral edema (HA, confusion, papilledema) Severe SVC — emergent intervention
Lung cancer (small cell, NSCLC) as cause 75 % of SVC syndrome cases
NHL (DLBCL, lymphoblastic, mediastinal B-cell) 15 %; histology-driven treatment
Catheter / port thrombosis Increasing cause; thrombolysis ± stent
Tissue diagnosis FIRST before empiric Tx Unless airway / cerebral edema
Stenting Rapid relief; first-line for malignant SVC
Steroids + RT For radiosensitive tumors (lymphoma, SCLC)
Lymphoma → systemic chemo alone often sufficient Avoid mediastinal RT if possible (avoids tissue distortion + late effects)

分類與診斷

Diagnostic Criteria

  • Clinical: facial / neck / arm swelling + dilated collaterals + dyspnea + Pemberton sign (face flushes when arms raised).
  • CT chest with IV contrast confirms obstruction + identifies cause.
  • Tissue diagnosis (biopsy) before treatment unless emergent airway / cerebral edema.

Workup

  • CT chest + neck with contrast — confirms SVC obstruction, defines extent, identifies tumor.
  • CXR (mediastinal mass, pleural effusion).
  • Tissue diagnosis by least-invasive route: sputum cytology → bronchoscopy → mediastinoscopy → CT-guided biopsy. Lymph node excision if accessible.
  • Echo to assess cardiac function (some malignant SVC have pericardial effusion + tamponade overlap).
  • Doppler / venogram of upper extremity if catheter-related thrombosis suspected.
  • Coagulation panel before invasive procedures.

治療

Treatment Algorithm

flowchart TD
  A[Suspected SVC syndrome] --> B[CT chest + neck with contrast]
  B --> C{Severity}
  C -- airway / cerebral edema --> D[Emergent intervention<br>endovascular stent + steroids<br>biopsy AFTER stabilization]
  C -- non-emergent --> E[Pursue tissue diagnosis FIRST<br>then disease-specific treatment]
  E --> F{Tumor type}
  F -- SCLC / lymphoma (radiosensitive) --> G[Systemic chemotherapy ± RT<br>often sufficient without stent]
  F -- NSCLC --> H[Stenting often used + chemo/RT/IO]
  F -- catheter thrombosis --> I[Anticoagulation + remove catheter or thrombolysis<br>± stent if persistent obstruction]
  D --> J[Diuretics + head-of-bed elevation + supportive O₂]
  G --> J
  H --> J
  I --> J

陷阱與考點

Pearls / Pitfalls

  • Get a tissue diagnosis BEFORE empiric treatment unless emergent (airway, cerebral edema). Steroids before biopsy can render lymphoma biopsy non-diagnostic.
  • Endovascular stenting is first-line for rapid relief of malignant SVC syndrome — can be done in <24 h with experienced IR. Often combined with chemo / RT.
  • SCLC + SVC → systemic chemo (etoposide-platin) usually resolves without stenting.
  • Lymphoma + SVC → R-CHOP / DA-EPOCH-R typically resolves; mediastinal RT considered only after chemo response.
  • Catheter-related SVC thrombosis — anticoagulation; thrombolysis if extensive; remove catheter if not essential, or attempt salvage with anticoag.
  • Avoid IV access in upper extremities during SVC syndrome (poor return; risk of extravasation) — use lower extremity or central femoral access.
  • Don't sit patient supine — head-up positioning helps. Diuretics may briefly help (caution: dehydration worsens prognosis if cancer-related).
  • SVC syndrome from indwelling lines is increasingly common (catheters, ports, ICDs) — counsel + screen for symptoms.
  • Cerebral edema → stenting + steroids urgently.
  • Recurrent SVC syndrome in cancer survivor → fibrosis from prior RT or recurrent disease — venogram + stent.

延伸

Cross-references

相關題目

  • Q-187 — SVC syndrome — initial workup
  • Q-188 — SVC — emergent stenting
  • Q-189 — SVC syndrome from primary mediastinal B-cell lymphoma (PMBL)

來源

Sources

Footnotes

  1. Lepper PM, Ott SR, Hoppe H, et al. Superior vena cava syndrome in thoracic malignancies. Respiratory Care 2011;56(5):653–666. doi:10.4187/respcare.00947.